InvestorsHub Logo
Followers 496
Posts 32155
Boards Moderated 0
Alias Born 03/12/2014

Re: None

Friday, 07/19/2024 8:43:08 PM

Friday, July 19, 2024 8:43:08 PM

Post# of 153

This is humongous news fir alzheimer

NKGen will present data on SNK01’s ability to reduce a-synuclein in Alzheimer’s patients, which is significant given that a-synuclein has been shown to correlate with worse cognitive function in Alzheimer’s disease. Presentation details are as follows:


Poster Title: Subjects treated with expanded non-genetically modified autologous Natural Killer cells (SNK01) show improved changes in CSF a-synuclein and in cognitive function
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKGN News